Splenic rupture in a patient with plasma cell myeloma following G-CSF/GM-CSF administration for stem cell transplantation and review of the literature
| Autor: | M Morrison, Stephanie F. Williams, D Variakojis, R Veerappan |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Male
medicine.medical_specialty Internal medicine Plasma Cell Myeloma Granulocyte Colony-Stimulating Factor medicine Humans Progenitor cell Transplantation Hematology business.industry Granulocyte-Macrophage Colony-Stimulating Factor Splenic Rupture Middle Aged Hematopoietic Stem Cell Mobilization Tissue Donors Granulocyte colony-stimulating factor Granulocyte macrophage colony-stimulating factor Immunology Stem cell Complication business Multiple Myeloma medicine.drug |
| Zdroj: | Bone marrow transplantation. 40(4) |
| ISSN: | 0268-3369 |
| Popis: | Recipients of granulocyte-colony stimulating factor/granulocyte macrophage-colony stimulating factor are not only individuals with underlying disorders, but also healthy donors undergoing peripheral blood progenitor cell (PBPC) mobilization. In addition to the known adverse effects associated with G-CSF, complications such as splenic rupture have also been reported. A review of the English literature, with addition of a patient with plasma cell myeloma, reveals that splenic rupture occurs not only in patients with underlying disease, but also in healthy PBPC donors. Although the cause of splenic rupture does not appear to be associated with any specific condition, physicians should be alerted to the possibility of this potentially fatal complication in individuals receiving G-CSF therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|